Outcomes of Thalassemia Patients Undergoing Hematopoietic Stem Cell Transplantation by Using a Standard Myeloablative versus a Novel Reduced-Toxicity Conditioning Regimen According to a New Risk Stratification

✍ Scribed by Anurathapan, Usanarat; Pakakasama, Samart; Mekjaruskul, Pimsiri; Sirachainan, Nongnuch; Songdej, Duantida; Chuansumrit, Ampaiwan; Charoenkwan, Pimlak; Jetsrisuparb, Arunee; Sanpakit, Kleebsabai; Pongtanakul, Bunchoo; Rujkijyanont, Piya; Meekaewkunchorn, Arunotai; Sruamsiri, Rosarin; Ungkanont, Artit; Issaragrisil, Surapol; Andersson, Borje S.; Hongeng, Suradej

• Book ID: 127023799
• Publisher: Elsevier Science
• Year: 2014
• Tongue: English
• Weight: 834 KB
• Volume: 20
• Category: Article
• ISSN: 1083-8791
• DOI: 10.1016/j.bbmt.2014.07.016